Evidence map›Paper›PMID 34860163›Full record

ArticleBalkan medical journal2021

The Genetic Analysis of Cystic Fibrosis Patients With Seven Novel Mutations in the CFTR Gene in the Central Anatolian Region of Turkey.

Murat Erdoğan, Mehmet Köse, Sevgi Pekcan, Melih Hangül, Burhan Balta, Aslıhan Kiraz, Gizem Akıncı Gönen, Ayşe Gül Zamani, Mahmut Selam Yıldırım, Tuğba Ramaslı Gürsoy and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Balkan medical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Identification and Characterization of a Rare Exon 22 Duplication inInternational journal of molecular sciences · 2025
    Article
  3. Article
  4. Article
  5. Heliyon · 2024
    Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Murat ErdoğanDepartment of Medical Genetics, Kayseri Training and Research Hospital, Kayseri, Turkey.
Mehmet KöseDivision of Pediatric Pulmonology, Department of Pediatrics, Erciyes University, Kayseri, Turkey.
Sevgi PekcanMeram Medicine Faculty, Division of Pediatric Pulmonology, Department of Pediatrics, Necmettin Erbakan University, Konya, Turkey.
Melih HangülDivision of Pediatric Pulmonology, Department of Pediatrics, Erciyes University, Kayseri, Turkey.
Burhan BaltaDepartment of Medical Genetics, Kayseri Training and Research Hospital, Kayseri, Turkey.
Aslıhan KirazDepartment of Medical Genetics, Kayseri Training and Research Hospital, Kayseri, Turkey.
Gizem Akıncı GönenDepartment of Medical Genetics, Kayseri Training and Research Hospital, Kayseri, Turkey.
Ayşe Gül ZamaniMeram Medicine Faculty, Department of Medical Genetics, Necmettin Erbakan University, Konya, Turkey.
Mahmut Selam YıldırımMeram Medicine Faculty, Department of Medical Genetics, Necmettin Erbakan University, Konya, Turkey.
Tuğba Ramaslı GürsoyDivision of Pediatric Pulmonology, Department of Pediatrics, Gazi University, Ankara, Turkey.
Fatih EzguDepartment of Pediatric Metabolic Disorders and Pediatric Genetics, Gazi University, Ankara, Turkey.
Tuğba Şişmanlar EyüpoğluDivision of Pediatric Pulmonology, Department of Pediatrics, Gazi University, Ankara, Turkey.
Ayse Tana AslanDivision of Pediatric Pulmonology, Department of Pediatrics, Gazi University, Ankara, Turkey.
Gazi University · TRKayseri Eğitim ve Araştırma Hastanesi · TRErciyes University · TRNecmettin Erbakan University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCystic fibrosis, a pulmonary disease which is an autosomal recessive, inherited, multisystemic genetic disease commonly seen in the Caucasian race, is the most frequent cause of mortality and morbidity. So far, more than 2000 disease-causing gene variants have been found and this number has been increasing with the studies conducted. Although there is not yet enough data that include the Turkish population, the recent increase of studies is noteworthy.

aimsTo discover the genetic variation in patients diagnosed with cystic fibrosis in the Central Anatolian region. STUDY

designCross-sectional study.

methodsThe study was carried out in the Central Anatolian region in 3 pediatric pulmonology departments (Kayseri, Konya, and Ankara) in Turkey between July 2014 and December 2017. The Sanger and Next Generation Sequence analyses were used for exon and exon-intron boundaries in the cystic fibrosis transmembrane conductance regulatory (CFTR) gene, and in selected patients, mutation analysis was performed using the Multiplex Ligation-dependent Probe Amplification technique for large deletions and duplications.

resultsCFTR gene analysis was performed for 316 patients and 215 of them were genetically diagnosed with cystic fibrosis. Sixtythree different variants were defined in these patients and 7 of these were large deletions/duplications detected with the MLPA method. The most frequent variants were F508del (29.6%), G85E (8.2%), N1303K (8.2%), Y515* (7.5%), and G542* (3.4%).

conclusionUsing sequencing and Multiplex Ligation-dependent Probe Amplification methods, the identification of seven new mutations that were not previously reported in the literature contributes to a better understanding of the heterogeneous nature of CFTR mutations in the Turkish population. When no mutations are detected (pathogenic/probably pathogenic) in clinically compatible cases, Multiplex Ligationdependent Probe Amplification analysis contributes significantly to the diagnosis.

Indexed as

ChildCross-Sectional StudiesCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorHigh-Throughput Nucleotide SequencingHumansMultiplex Polymerase Chain ReactionMutationTurkeyCFTR protein, humanCystic Fibrosis Transmembrane Conductance Regulator

Identifiers

PMID34860163
PMCPMC8880976
OpenAlexW3205762762

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.